1.OMERACT: An international initiative to improve outcome measurement in rheumatology

作　　者：Peter Tugwell ;Maarten Boers ;Peter Brooks 等

出　　处：Trials. 2007 ;8(1):38.doi:10.1186/1745-6215-8-38

出版社：BioMed Central

文章 ID：31776604

文章详细全文下载
2.Consensus on the need for a hierarchical list of patient-reported pain outcomes for meta-analyses of knee osteoarthritis trials

作　　者：Louise Klokker ;Lara J Maxwell ;Peter Juni 等

出　　处：Trials. 2015 ;16(1):1.doi:10.1186/1745-6215-16-S1-P36

出版社：BioMed Central

文章 ID：175815517

文章详细全文下载
3.A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set

作　　者：Alessandro Chiarotto ;Caroline B Terwee ;Richard A Deyo 等

出　　处：Trials. 2014 ;15(1):511.doi:10.1186/1745-6215-15-511

出版社：BioMed Central

文章 ID：95956213

文章详细全文下载
4.How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

作　　者：Cecilia A. C. Prinsen ;Sunita Vohra ;Michael R. Rose 等

出　　处：Trials. 2016 ;17(1):449.doi:10.1186/s13063-016-1555-2

出版社：BioMed Central

文章 ID：185387997

文章详细全文下载
5.Outcome measures in rheumatoid arthritis randomised trials over the last 50 years

作　　者：Jamie J Kirkham ;Maarten Boers ;Peter Tugwell 等

出　　处：Trials. 2013 ;14(1):324.doi:10.1186/1745-6215-14-324

出版社：BioMed Central

文章 ID：95193303

文章详细全文下载
6.Has the rheumatoid arthritis (RA) core outcome set influenced the selection of study outcome measures?

作　　者：Jamie Kirkham ;Maarten Boers ;Peter Tugwell 等

出　　处：Trials. 2013 ;14(1):O66.doi:10.1186/1745-6215-14-S1-O66

出版社：BioMed Central

文章 ID：215802988

文章详细
7.Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial

作　　者：Linda Hartman ;Linda A. Rasch ;Thomas Klausch 等

出　　处：Trials. 2018 ;19(1):67.doi:10.1186/s13063-017-2396-3

出版社：BioMed Central

文章 ID：213573502

文章详细全文下载
8.Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial

作　　者：Maike H. M. Wientjes ;Sadaf Atiqi ;Gerrit Jan Wolbink 等

出　　处：Trials. 2021 ;22(1):1-9.doi:10.1186/s13063-021-05358-7

出版社：BioMed Central

文章 ID：263093567

文章详细全文下载

	有本地全文	7篇
	有全文链接	1篇

	Maarten Boers	8篇
	Peter Tugwell	5篇
	Mike Clarke	3篇
	Caroline B Terwee	2篇
	Paula R Williamson	2篇

	Rachelle Buchbinder	2篇
	Robin Christensen	2篇
	Adam M Pearson	1篇
	Alessandro Chiarotto	1篇
	Alfons A. den Broeder	1篇
	Annick de Vries	1篇
	Bart J. F. van den Bemt	1篇
	Bart W Koes	1篇
	Caroline B. Terwee	1篇
	Cecilia A. C. Prinsen	1篇
	Chris G Maher	1篇
	Chung-Wei C Lin	1篇
	Daniela Opris	1篇
	David Tovey	1篇
	Dennis C Turk	1篇
	Francisco M Kovacs	1篇
	Frank Buttgereit	1篇
	Gerrit Jan Wolbink	1篇
	Hans W. J. Bijlsma	1篇
	Jamie J Kirkham	1篇
	Jamie Kirkham	1篇
	Jasvinder A Singh	1篇
	Jose A. P. Da Silva	1篇
	Jozef Rovenský	1篇
	Lara J Maxwell	1篇
	Leanne Idzerda	1篇
	Lee Simon	1篇
	Leonardo OP Costa	1篇
	Leonie M. Middelink	1篇
	Linda A. Rasch	1篇
	Linda Hartman	1篇
	Louise Klokker	1篇
	Lyn March	1篇
	Maike H. M. Wientjes	1篇
	Margreth Grotle	1篇

全文

出版年度

作者

文章类型

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Maarten Boers")))) )) ) )"

	2021	1篇
	2018	1篇
	2016	1篇
	2015	1篇
	2014	1篇

	2013	2篇
	2007	1篇